Alpha-Lipoic Acid and Diabetic Neuropathy
- 1 January 2009
- journal article
- Published by JCFCorp SG PTE LTD in The Review of Diabetic Studies
- Vol. 6 (4), 230-236
- https://doi.org/10.1900/rds.2009.6.230
Abstract
Diabetic neuropathy presents a major public health problem. It is defined by the symptoms and signs of peripheral nerve dysfunction in diabetic patients, in whom other causes of neuropathy have been excluded. Pathogenetic mechanisms that have been implicated in diabetic neuropathy are: a) increased flux through the polyol pathway, leading to accumulation of sorbitol, a reduction in myo-inositol, and an associated reduced Na+-K+-ATPase activity, and b) endoneurial microvascular damage and hypoxia due to nitric oxide inactivation by increased oxygen free radical activity. Alpha-lipoic acid seems to delay or reverse peripheral diabetic neuropathy through its multiple antioxidant properties. Treatment with alpha-lipoic acid increases reduced glutathione, an important endogenous antioxidant. In clinical trials, 600 mg alpha-lipoic acid has been shown to improve neuropathic deficits. This review focuses on the relationship of alpha-lipoic acid and auto-oxidative glycosylation. It discusses the impact of alpha-lipoic acid on hyperglycemia-induced oxidative stress, and examines the role of alpha-lipoic acid in preventing glycation process and nerve hypoxia.Keywords
This publication has 88 references indexed in Scilit:
- Continuous -Opioid Receptor Activation Reduces Neuronal Voltage-Gated Sodium Channel (NaV1.7) Levels through Activation of Protein Kinase C in Painful Diabetic NeuropathyJournal of Neuroscience, 2008
- Diabetic neuropathy: new strategies for treatmentDiabetes, Obesity and Metabolism, 2007
- Irbesartan and Lipoic Acid Improve Endothelial Function and Reduce Markers of Inflammation in the Metabolic SyndromeCirculation, 2005
- Short‐term hyperglycemia produces oxidative damage and apoptosis in neuronsThe FASEB Journal, 2005
- Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (α-lipoic acid): A two year multicenter randomized double-blind placebo-controlled trial (ALADIN II)Free Radical Research, 1999
- The role of oxidative stress in neuropathy and other diabetic complicationsDiabetes/Metabolism Research and Reviews, 1995
- α-Lipoic Acid Supplementation Prevents Symptoms of Vitamin E DeficiencyBiochemical and Biophysical Research Communications, 1994
- Effects of glucose on sorbitol pathway activation, cellular redox, and metabolism of myo-inositol, phosphoinositide, and diacylglycerol in cultured human retinal pigment epithelial cells.JCI Insight, 1994
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsThe New England Journal of Medicine, 1988
- Sodium- and energy-dependent uptake of myo-inositol by rabbit peripheral nerve. Competitive inhibition by glucose and lack of an insulin effect.JCI Insight, 1982